medigraphic.com
Órgano de Difusión de la Asociación Académica Panamericana de Medicina Familiar A.C.

2022, Number 1

<< Back Next >>

Arch Med Fam 2022; 24 (1)

Prevalence and Clinical Evolution of Patients with COVID-19 in a Family Medicine Unit of Cd. Obregon, Sonora, Mexico

Esquer PMD, Chávez AAI, Carballo DC, Barrios OC

Language: Spanish
References: 17
Page: 23-29
PDF size: 153.95 Kb.


ABSTRACT

Objective: To determine the prevalence and clinical evolution of patients with COVID19 in the Family Medicine Unit No. 1 of Cd. Obregon, Sonora, Mexico. Methods: Observational, descriptive, cross-sectional, retrospective design. The total registration of COVID-19 positive patients was taken from April to October 2021, obtaining 401 records, through the Online Notification System for Epidemiological Surveillance. Non-probabilistic sampling for convenience, with subsequent review of files and analysis through descriptive statistics. Results:From a total of 219,203 beneficiaries, 401 records were obtained, 30 were eliminated. A prevalence of 0.18% was calculated, with a mean age of 39 years and a female sex of 56.1%. The most frequent occupation was nursing (18.1%). The most affected geographical area was Casa Blanca (5.4%). Obesity was the predominant comorbidity: 18.1%. 87.9% presented headache, 3% pneumonia. A total of 12 patients (3.2%) required intubation. 41.2% required prolonged disability, 96.2% showed improvement, and 14 patients (3.7%) died. Conclusions: We consider that this study could serve as a basis for the analysis of new research related to COVID-19, in the State of Sonora (Mexico), because it provides essential data in relation to this disease.


REFERENCES

  1. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet. 2020; 395: 497–506.

  2. Ghebreyesus, T.A. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19-11. WHO: Geneva, Switzerland, 2020.

  3. Su, S., Wong, G., Shi, W., Liu, J., Lai, A.C.K., Zhou, J., Et al. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol. 2016; 24: 490–502.

  4. Mousavizadeh L, Ghasemi S. Genotype and Phenotype of COVID-19: Their roles in pathogenesis. J. Microbiol. Immunol. Infect. 2020, in press.

  5. Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S.; et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181: 271– 280.

  6. Guan WJ, Ni ZY, Hu Y, et al. China Medical Treatment Expert Group for COVID19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18):1708-20.

  7. Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus Disease 2019 Case Surveillance — United States, January 22–May 30, 2020. MMWR Morb Mortal Wkly Rep 2020;69:759–65.

  8. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020.

  9. Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F. et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med 2020; 288: 192-206.

  10. Adhikari SP. Meng S, Wu YJ. et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty 2020; 9: 29.

  11. McIntosh K., Hirsch MS., Bloom A. Coronavirus disease 2019 (COVID-19): Clinical features. UpToDate Wolters Kluwer.[Internet]. 2020. [17 May 2020] Disponible en: https://www.cmim.org/PDF_covid/Coronavirus_disease2019_COVID19_UpToDate2.pdf

  12. Pérez Abreu MR, Gómez Tejeda JJ, Dieguez Guach RA. Características clínicoepidemiológicas de la COVID-19. Rev Haban Cienc Méd [Internet]. 2020 [02 sept 2020]; 19(2):e_3254. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3254/2505

  13. Padilla-Santamaría F, Maya-Franco L, Ferman-Cano F. COVID-19 en México: Panorama Epidemiológico. Rev Cadena Cereb. 2020; 4(1): 31-42.

  14. Who.in [Internet]. Geneva: World Health Organization; 2020 [actualizado 02 sep 2020; citado 02 sept 2020]. Disponible en: https://covid19.who.int/

  15. Coronavirus.gob.mx [Internet]. México: Dirección General de Epidemiología; 2020 [actualizado 02 sept 2020; citado 02 sept 2020]. Disponible en https://coronavirus.gob.mx/datos/

  16. Covid19data.unison.mx [Internet]. Sonora. Universidad de Sonora; 2020 [actualizado 02 sept 2020; citado 02 sept 2020] Disponible en https://covid19data.unison.mx/#municipios

  17. Barrientos-Gutiérrez T, Alpuche-Aranda C, Lazcano-Ponce E, Pérez-Ferrer C, Rivera-Dommarco J. La salud pública en la primera ola: una agenda para la cooperación ante Covid-19. Salud Pública Mex. 2020;62:598-606.




2020     |     www.medigraphic.com